Total Payments
$23,952
2024 Payments
$332.38
Companies
46
Transactions
674
Medicare Patients
1,577
Medicare Billing
$335,749
Payment Breakdown by Category
Research$15,009 (62.7%)
Food & Beverage$8,725 (36.4%)
Other$164.37 (0.7%)
Education$34.29 (0.1%)
Gifts$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,009 | 2 | 62.7% |
| Food and Beverage | $8,725 | 667 | 36.4% |
| Entertainment | $164.37 | 1 | 0.7% |
| Education | $34.29 | 3 | 0.1% |
| Gift | $20.00 | 1 | 0.1% |
Payments by Type
Research
$15,009
2 transactions
General
$8,944
672 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $14,624 | 1 | $0 (2019) |
| Abbott Laboratories | $1,974 | 132 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $1,063 | 106 | $0 (2023) |
| PFIZER INC. | $999.24 | 115 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $893.64 | 87 | $0 (2024) |
| AbbVie Inc. | $508.85 | 46 | $0 (2023) |
| Boston Scientific Corporation | $481.77 | 20 | $0 (2023) |
| SCILEX PHARMACEUTICALS INC. | $387.87 | 32 | $0 (2024) |
| West-Ward Pharmaceuticals | $384.62 | 1 | $0 (2017) |
| Valinor Pharma, LLC | $246.69 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.38 | 27 | Valinor Pharma, LLC ($220.92) |
| 2023 | $930.34 | 67 | Abbott Laboratories ($206.81) |
| 2022 | $1,167 | 90 | Abbott Laboratories ($460.76) |
| 2021 | $2,281 | 188 | Abbott Laboratories ($1,022) |
| 2020 | $505.41 | 35 | Collegium Pharmaceutical, Inc. ($199.96) |
| 2019 | $15,609 | 87 | Eli Lilly and Company ($14,624) |
| 2018 | $1,581 | 101 | PFIZER INC. ($408.22) |
| 2017 | $1,546 | 79 | West-Ward Pharmaceuticals ($384.62) |
All Payment Transactions
674 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Gastroenterology | ||||||
| 09/27/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $9.94 | General |
| 06/14/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/17/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Pain Management | ||||||
| 04/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Analgesic | ||||||
| 04/05/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Gastroenterology | ||||||
| 03/21/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/28/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/21/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Analgesic | ||||||
| 02/14/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/26/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Analgesic | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS | Eli Lilly and Company | $14,624 | 1 |
| Opioid PMR Study | West-Ward Pharmaceuticals | $384.62 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 329 | 1,390 | $416,668 | $85,041 |
| 2022 | 9 | 416 | 1,419 | $478,431 | $100,686 |
| 2021 | 11 | 391 | 1,195 | $347,096 | $77,960 |
| 2020 | 12 | 441 | 1,168 | $343,075 | $72,061 |
Total Patients
1,577
Total Services
5,172
Medicare Billing
$335,749
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 720 | $272,649 | $64,822 | 23.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 14 | 27 | $36,974 | $6,337 | 17.1% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 13 | 25 | $37,016 | $3,080 | 8.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 12 | 20 | $13,095 | $2,953 | 22.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 12 | 17 | $26,661 | $2,724 | 10.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 29 | 39 | $6,579 | $2,321 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 29 | $7,764 | $1,873 | 24.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 11 | 18 | $15,435 | $883.98 | 5.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 36 | 495 | $495.00 | $46.73 | 9.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 689 | $253,552 | $62,711 | 24.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 14 | 35 | $46,865 | $9,264 | 19.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 48 | 68 | $23,324 | $7,686 | 33.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 15 | 38 | $51,912 | $4,388 | 8.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 49 | 71 | $13,206 | $4,357 | 33.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 16 | 25 | $20,253 | $4,252 | 21.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 16 | 26 | $34,992 | $3,960 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 37 | $9,620 | $2,480 | 25.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 15 | 33 | $24,310 | $1,551 | 6.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 31 | 397 | $397.00 | $39.22 | 9.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 401 | $72,581 | $37,837 | 52.1% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 16 | 41 | $44,608 | $9,758 | 21.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Facility | 2021 | 21 | 42 | $46,326 | $7,215 | 15.6% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Facility | 2021 | 26 | 45 | $56,416 | $5,391 | 9.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves with imaging guidance | Facility | 2021 | 20 | 76 | $66,956 | $3,609 | 5.4% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 29 | 30 | $6,000 | $3,433 | 57.2% |
About Dr. Matthew Doust, MD
Dr. Matthew Doust, MD is a Specialist healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720171143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Doust, MD has received a total of $23,952 in payments from pharmaceutical and medical device companies, with $332.38 received in 2024. These payments were reported across 674 transactions from 46 companies. The most common payment nature is "" ($15,009).
As a Medicare-enrolled provider, Doust has provided services to 1,577 Medicare beneficiaries, totaling 5,172 services with total Medicare billing of $335,749. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Anesthesiology, Interventional Pain Medicine
- Location Phoenix, AZ
- Active Since 09/30/2006
- Last Updated 03/07/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1720171143
Products in Payments
- Proclaim IPG (Device) $990.07
- XTAMPZA (Drug) $899.24
- LYRICA (Drug) $861.40
- RELISTOR (Drug) $790.59
- PROCLAIM (Device) $605.41
- Morphine Sulfate ER tablets (Drug) $384.62
- MOVANTIK (Drug) $304.50
- UBRELVY (Drug) $301.12
- ZTLido (Drug) $222.32
- Movantik (Drug) $214.28
- Nalocet (Drug) $210.99
- Amitiza (Drug) $185.29
- QULIPTA (Drug) $176.79
- Prometra II (Device) $164.37
- Senza Spinal Cord Stimulation System (Device) $160.63
- RELISTOR ORAL (Drug) $143.83
- 32 CONTACT (Device) $139.25
- BELBUCA (Drug) $139.08
- Nalu Neurostimulation System (Device) $124.67
- DRG IPGs (Device) $120.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Phoenix
Dr. Anthony Yeung
Specialist — Payments: $16.8M
Specialist $16.8M
Christopher Yeung, M.d, M.D
Specialist — Payments: $3.6M
Specialist $3.6M
Dr. John Mulcahy, M.d, M.D
Specialist — Payments: $1.2M
Specialist $1.2M
Eric Eross, Do, DO
Specialist — Payments: $971,598
Specialist $971,598
Dr. Richard Dolinar, M.d, M.D
Specialist — Payments: $721,885
Specialist $721,885
Dr. Jerome Grove, Md, MD
Specialist — Payments: $213,369
Specialist $213,369